GleamWall
中文EN

MRVI MARAVAI LIFESCIENCES HOLDINGS, INC.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1823239 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY10.8%
TTM net income YoY45.8%
TTM EPS YoY47.6%
Revenue 3-yr CAGR-20.2%
Net income 3-yr CAGR—

Margins

Gross margin39.1%
Operating margin-45.4%
Net margin-30.8%
FCF margin-5.9%
EBITDA margin-35.1%

Returns

ROE-29.8%
ROA-9.1%
ROIC (approx.)-27.0%
Asset turnover0.29x

Leverage & solvency

Liabilities / assets43.3%
Debt / equity0.75x
Current ratio4.66x
Interest coverage-4.57x

Cash quality & payout

Operating cash flow / net income0.08x
Accruals ratio-8.4%
Payout ratio—
Capex / revenue3.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$185.74M$259.19M
Cost of revenue$151.75M$150.88M
Gross profit$33.99M$108.31M
R&D expense$17.40M$19.22M
SG&A expense$145.12M$161.77M
Operating income-$215.27M-$235.62M
Interest expense$26.99M$47.70M
Pretax income-$234.97M-$261.48M
Income tax-$4.21M-$1.86M
Net income-$130.77M-$144.85M
EBITDA-$191.71M-$214.76M
EPS (basic)-0.90-1.05
EPS (diluted)-0.90-1.05
Weighted avg. shares (diluted)144.36M137.91M
Balance sheet
Cash & equivalents$216.89M$322.40M
Receivables$25.50M$38.52M
Inventory$40.49M$50.08M
Current assets$296.25M$429.15M
PP&E, net$151.48M$164.47M
Goodwill$129.43M$159.88M
Intangibles$151.54M$194.96M
Total assets$770.58M$1.01B
Current liabilities$44.92M$56.97M
Short-term debt$5.44M$5.44M
Long-term debt$286.33M$290.49M
Total debt$291.77M$295.93M
Total liabilities$397.87M$431.04M
Shareholders' equity$212.38M$325.29M
Net debt$74.88M-$26.47M
Cash flow statement
Operating cash flow-$57.57M$7.46M
Capital expenditure$13.15M$29.66M
Free cash flow-$70.72M-$22.19M
Investing cash flow-$31.41M-$24.32M
Financing cash flow-$16.50M-$235.71M
Depreciation & amortization$23.56M$20.85M
Stock-based compensation$30.17M$49.41M

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.